Pharma News
FDA Approves Vanda Pharmaceuticals' Fanapt to Treat Adults with Bipolar I Disorder
Fanapt was previously approved by the FDA in 2009 as an antipsychotic treatment for schizophrenia.
Source link
#FDA #Approves #Vanda #Pharmaceuticals039 #Fanapt #Treat #Adults #Bipolar #Disorder